AzTrials
AzTrials

Posttraumatic Stress SymptomsNCT07147855

A Feasibility Mixed Methods Study of the Intervention Take Your Sexuality Back for Sexually Traumatized Women.

A study testing Take your sexuality back in people with Posttraumatic Stress Symptoms and Sexual Abuse, run by Sykehuset Telemark at 1 site in Norway.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study looks at the potential effects of a new group treatment called "Take Your Sexuality Back", designed for women who have experienced sexual trauma. Investigators will collect information in two ways-through forms that participants fill out themselves and through ECG measurements during a stress tests. Read more about this study

Who is it for?
Ages 18 years and older, women only
What is being tested?
Take your sexuality back
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteNorway
Study dates
Sep 2025to Sep 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • A history of sexual trauma.
  • Experience trauma-related sexual problems.
  • Age between 18 and 65 years.
  • Enough competence in Norwegian to participate in a psychoeducational group.

Who cannot join

  • Acute suicidality.
  • Serious substance abuse interfering with treatment
  • Severe dissociative or psychotic disorders.
  • Current life crisis interfering with treatment.
  • Living in an abusive relationship. -

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Idun Røseth, PhD contact

0047-41200462

IDUROE@sthf.no

Siv Åshild Billington contact

0047-97777857

Siv.Ashild.Billington@sthf.no

Norway1 site
  • Sykehuset Telemark HF

    Skien

    Malin Wästlund, PhD-student, 0047-95135546, malin.wastlund@nenett.no

    Idun Røseth, PhD

Other trials in Norway

About this study

Official title: Take Your Sexuality Back - a Feasibility Study of a New Intervention for Sexually Traumatized Women: Preliminary Evaluations of Efficacy and Outcome Measurements

This study looks at the potential effects of a new group treatment called "Take Your Sexuality Back", designed for women who have experienced sexual trauma. Investigators will collect information in two ways-through forms that participants fill out themselves and through ECG measurements during a stress tests. Data will be collected before the treatment, right after it, and again three months later. When all data are collected and analyzed investigators will carry out in-depth interviews with participants and explore how they felt about being tested and how they understand the results -especially if some numbers look unusual or surprising. The goal with this study is to create a strong foundation for a future larger-scale study of the treatment by testing the methods, estimating the size of possible effects and identify outcome measurements that are experienced as meaningful to the participants.

Being tested
Take your sexuality back
Medical subject headings
Sexual Trauma

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Take your sexuality backBehavioural

    A 12 weeks group program.

Study groups in NCT07147855
Study groupRoleWhat they receive
Treatment group "Take your sexuality back"ExperimentalA 12 week group intervention
Receives: Behavioral: Take your sexuality back

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. PTSD-symptoms and complex PTSD symptoms

    The international trauma questionnaire (ITQ). Zero (0) is equivalent to nothing and 4 indicates extremely. Higher scores mean worse outcome.

    Measured: From enrollment to 3 month after end of treatment (12 weeks treatment)

  2. Sexual satisfaction

    The Sexual Satisfaction Scale for women (SSS-W). Different Likert scales. Higher scores mean worse outcome. Higher scores mean better outcome.

    Measured: From enrollment to 3 months after end of treatment (12 weeks intervention)

  3. Sexual shame

    The Sexual shame index-revised (SSI-R). One (1) is equivalent to strongly disagree and 6 indicates strongly agree. Higher scores mean worse outcome.

    Measured: From enrollment to 3 months after end of treatment (12 weeks intervention).

  4. Interoceptive awareness

    The Multidimensional Assessment of Interoceptive Awareness (MAYA 2). Zero is equivalent with never and 5 indicates always. Higher scores mean better outcome.

    Measured: From enrollment to 3 months after end of treatment (12 weeks intervention).

  5. Responses to script-driven imagery.

    The Responses to script-driven imagery (RSDI) measures emotional, cognitive, and physiological responses in the script-driven imagery procedure. Zero is equivalent to "not at all" and six (6) indicates "very much". Higher scores mean worse outcome.

    Measured: From enrollment to 3 months after end of treatment (12 weeks intervention).

  6. Touch body map

    Touch Body Map is an instrument for mapping how the body reacts to touch. Participants color the outlines of a human figure with three colors to mark how different areas of the body react to touch form a loved one. The body map gives a non-verbal expression of how trauma is embodied. The percentage of the different colors will be calculated to assess possible changes through the process

    Measured: From enrollment to 3 months after end of the treatment (12 weeks intervention).

  7. Change in HRV and SampEn from pre-post and at follow up efter 3 month.

    Cardiovascular measurement (ECG) recorded during a script-driven imagery (SDI). HRV and SampEn.

    Measured: Enrollment to 3 months after end of treatment (12 weeks intervention).

  8. Participants experiences of being tested and their understanding of the results.

    In-depth interviews with focus on participants own experiences and understanding og the quantitative results.

    Measured: Three month after end of treatment, when all quantitative results are analyzed and calculated.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Aug 2025
  2. Study startSep 2025 (estimated)
  3. Primary completionSep 2026 (estimated)
  4. Study completionSep 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07147855
Sponsor's protocol ID
REK829297
Status last verified
Sep 2025
First submitted
22 Aug 2025
Last updated
8 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Data are sensitive and participants' anonymity cannot be guaranteed.

Questions about this trial

What is this clinical trial studying?

A study testing Take your sexuality back in people with Posttraumatic Stress Symptoms and Sexual Abuse, run by Sykehuset Telemark at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 8 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Idun Røseth, PhD (0047-41200462, IDUROE@sthf.no), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

PTSD-symptoms and complex PTSD symptoms (time frame: From enrollment to 3 month after end of treatment (12 weeks treatment)). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in